Pharma Giants Face Patent Cliff: Analyst Downgrades
The Pharmaceutical Stock Landscape: Assessing Pfizer and Merck’s Outlook Recent fluctuations in the stock market have drawn attention to pharmaceutical giants Pfizer and Merck, raising concerns over patent cliffs and impending challenges. Despite initial apprehensions, subsequent reports offer a more optimistic outlook for both companies, largely due to forthcoming acquisitions.